Skip to main content
PMC home page
Age logoLink to Age
. 2016 Apr 2;38(2):44. doi: 10.1007/s11357-016-9907-0

ECG low QRS voltage and wide QRS complex predictive of centenarian 360-day mortality

Jan Szewieczek 1,✉, Zbigniew Gąsior 2, Jan Duława 3, Tomasz Francuz 4, Katarzyna Legierska 3, Agnieszka Batko-Szwaczka 1, Beata Hornik 5, Magdalena Janusz-Jenczeń 5, Iwona Włodarczyk 5, Krzysztof Wilczyński 1
PMCID: PMC5005906  PMID: 27039197

Abstract

We examined the electrocardiographic (ECG) findings of centenarians and associated them with >360-day survival. Physical and functional assessment, resting electrocardiogram and laboratory tests were performed on 86 study participants 101.9 ± 1.2 years old (mean ± SD) (70 women, 16 men) and followed for at least 360 days. Centenarian ECGs were assessed for left ventricular hypertrophy (LVH) according to the Romhilt–Estes score, Sokolow–Lyon criteria and Cornell voltage criteria which were positive for 12.8, 6.98, and 10.5 % of participants, respectively. Fifty-two study participants (60 %) survived ≥360 days. Multivariate logistic regression analysis revealed a negative relationship between 360-day survival and the following: R II <0.45 mV adjusted for CRP (odds ratio (OR) = 0.108, 95 % confidence interval (CI) = 0.034–0.341, P < .001), R aVF < 0.35 mV adjusted for CRP (OR = 0.151, 95 % CI = 0.039–0.584, P < .006), Sokolow–Lyon voltage <1.45 mV adjusted for CRP (OR = 0.178, 95 % CI = 0.064–0.492, P = .001), QRS ≥90 ms adjusted for CRP (OR = 0.375, 95 % CI = 0.144–0.975, P = .044), and Romhilt–Estes score ≥5 points adjusted for sex and Barthel Index (OR = 0.459, 95 % CI = 0.212–0.993, P = .048) in single variable ECG models. QRS voltage correlated positively with systolic and pulse pressure, serum vitamin B12 level, sodium, calcium, phosphorous, TIMP-1, and eGFR. QRS voltage correlated negatively with BMI, WHR, serum leptin, IL-6, TNF-α, and PAI-1 levels. QRS complex duration correlated positively with CRP; QTc correlated positively with TNF-α. Results suggest that Romhilt–Estes LVH criteria scores ≥5 points, low ECG QRS voltages (Sokolow–Lyon voltage <1.45 mV), and QRS complexes ≥90 ms are predictive of centenarian 360-day mortality.

Keywords: Centenarians, ECG, Low QRS voltage, Left ventricular hypertrophy

Background

Identification of electrocardiographic (ECG) findings predictive of centenarian survival would prove valuable in the clinical setting. The ECG remains one of the most ubiquitous diagnostic tools in medicine and is readily utilized for domiciled frail elderly patients. Survival prognosis of centenarians is especially important for making diagnostic and therapeutic decisions. Widespread specific cardiac anomalies have been documented by ECG in centenarians (Lakkireddy et al. 2003; Rabunal-Rey et al. 2012; Basile et al. 2012). Survival and ECG associations have been studied by Rabunal-Rey et al. (2012) who observed that atrial fibrillation is a prognostic factor for mortality and by Basile et al. (2012) who did not describe any ECG findings that are predictive of survival. While mildly elevated blood pressure has been associated with improved health status in centenarians (Szewieczek et al. 2011; Szewieczek et al. 2015a), consistently elevated blood pressure may lead to left ventricular hypertrophy (LVH). It follows then that a positive relationship between ECG LVH features and centenarian survival would be expected. However, LVH is a known risk factor for ischemic heart disease and death (Kannel et al. 1969; Kannel et al. 1970). Estes et al. (2015) demonstrated that the Romhilt–Estes score, traditionally used for ECG detection of LVH, may be applied to predict adverse outcomes in the general population. Despite poor correlation between electrocardiographic and echocardiographic features of LVH in centenarians (Martínez-Sellés et al. 2015), it seems reasonable to explore a possible association between ECG findings, especially LVH features, and survival probability in this specific age group. We also studied associations between ECG features and a range of clinical, metabolic, and inflammatory markers to ascertain possible influence on ECG features.

Methods

Participants

The study was carried out from January 2007 to August 2013. The data regarding >100-year-old inhabitants of Upper Silesia were obtained from the Silesian Voivodeship Administration Office in Katowice. In the year 2006, there were 389 centenarians living in Upper Silesia, accounting for 0.008 % of the total population of the area. Eight percent of addressees responded positively to invitation letters.

The study comprised of eighty-six 100.9 ± 1.2-year-old (mean ± SD) study participants (70 women and 16 men). The study group is defined in our previous papers (Szewieczek et al. 2015a, b).

Measurements

Patient assessment comprised of a structured interview, physical examination, functional assessment, resting electrocardiography, and blood sampling. A detailed description of the methods used, beyond ECG analysis, is presented in our previous papers (Szewieczek et al. 2015a, b). Romhilt–Estes score, Sokolow–Lyon criteria, and Cornell voltage criteria were used to assess left ventricular hypertrophy (Buxton et al. 2006). An electrocardiogram (ECG) was analyzed according to the ACC/AHA/HRS Clinical Data Standards (Buxton et al. 2006) and considered normal if the following criteria were met: sinus rhythm, no significant rhythm disorders, heart rate from 60 to 90/min, electrical axis from −30 to 90, PR interval from 0.12 to 0.20 s, QRS complex duration from 0.06 to 0.11 s, corrected QT interval (QTc, according to the Bazett’s formula) ≤0.43 s in males, and ≤0.45 s in females, no significant ventricular depolarization or repolarization changes, negative Romhilt–Estes score, Sokolow–Lyon criteria, and Cornell voltage criteria. QTc >0.45 s in males or >0.46 s in females was considered prolonged QT. Centenarians received follow-up phone calls at least 360 days after initial examination.

Statistical Analysis

Data was analyzed using STATISTICA software version 10 (StatSoft, Inc., USA; StatSoft Poland). Chi-square test, V-square test, and Fisher’s exact test were used for categorical variables, and nonparametric Mann–Whitney U test was used for quantitative variables to compare centenarians who survived 360 days with those who did not survive 360 days. Multivariate binary logistic regression was performed to assess electrocardiographic findings associated with 360-day survival. The variables were adjusted for clinical, functional, and laboratory factors. Multivariate analysis with backward elimination included variables that yielded P values of 0.1 or lower in the initial univariate analysis. The Kaplan–Meier method was used to estimate survival probability in subgroups of centenarians with respect to select variables, while differences between these subgroups were assessed with the Wilcoxon–Gehan statistic. Variables were tested for the value corresponding with the lowest P level. The nonparametric Spearman’s rank correlation coefficient was used to assess relationships between ECG, and clinical and laboratory measures. P values <0.05 were considered statistically significant.

Ethics

The study protocol was approved by the Bioethical Committee of the Medical University of Silesia. Written informed consent was obtained from each participant and/or their caregiver after the aim of the study, protocol, and risks were explained.

Results

Only seven study participants (8.14 %) presented with normal ECGs. Sixty-three participants (73.3 %) had sinus rhythm, 18 (20.9 %) had permanent atrial fibrillation, 1 had paroxysmal atrial fibrillation, 1 had paroxysmal atrial flutter, 1 had an implanted DDD pacemaker, and 2 had extrasinusal rhythms. Fifteen participants (17.4 %) presented with first-degree atrioventricular block, 17 (19.8 %) with right bundle branch block, and 4 (4.65 %) with left bundle branch block. Twenty-seven participants (31.4 %) had a prolonged QT interval. Electrocardiographic Romhilt–Estes score, Sokolow–Lyon criteria, and Cornell voltage criteria for LVH were positive for 12.8, 6.98, and 10.5 % of participants, respectively.

Fifty-two participants (60 %) survived 360 days or more. The proportion of males who died (10 of 16) was greater than females (24 of 70; P = .038). Beyond sex, survivors, as compared to nonsurvivors, did not differ significantly in most clinical variables (see Table 1 in our previous paper: Szewieczek et al. (2015b)). Nonsurvivors, when compared to survivors, had a longer QRS complex, right ventricular activation time and QTc, lower R wave amplitude in leads II, aVF, V5, and V6, and lower S wave amplitude in lead V1 (Table 1). No significant differences were found with respect to the proportion of participants with positive LVH, as tested by the Sokolow–Lyon criteria, Cornell voltage criteria, or Romhilt–Estes score. Participants with an R wave in lead II < 0.45 mV, R wave in lead aVF <0.35 mV, Sokolow–Lyon voltage (S wave in lead V1 + R wave in lead V5 or V6—whichever is greater) <1.45 mV, and QRS complex duration ≥0.09 s had diminished 360-day survival probability as compared with study participants with higher or lower values, respectively (Fig. 1). Multivariate logistic regression analysis revealed a negative relationship between 360-day survival and the following: R wave in lead II <0.45 mV adjusted for CRP (odds ratio (OR) = 0.108, 95 % confidence interval (CI) = 0.034–0.341, P < .001), R wave in lead aVF <0.35 mV adjusted for CRP (OR = 0.151, 95 % CI = 0.039–0.584, P < .006), Sokolow–Lyon voltage <1.45 mV adjusted for CRP (OR = 0.178, 95 % CI = 0.064–0.492, P = .001), QRS ≥90 ms adjusted for CRP (OR = 0.375, 95 % CI = 0.144–0.975, P = .044), and Romhilt–Estes score ≥5 adjusted for sex and Barthel Index (OR = 0.459, 95 % CI = 0.212–0.993, P = .048) in single ECG variable models. QRS amplitude correlated positively with systolic blood pressure, pulse pressure and serum vitamin B12, sodium, calcium, phosphorous, and TIMP-1 levels, as well as with eGFR. QRS amplitude correlated negatively with BMI, WHR, and serum leptin, IL-6, TNF-α, and PAI-1. QRS complex duration correlated positively with CRP and bilirubin level, and negatively with eGFR. QTc interval correlated positively with TNF-α (Table 2).

Table 1.

ECG measures in the study group

Variable Survivors (n = 52) Nonsurvivors (n = 34) Survivors versus nonsurvivors
Mean ± SD P
QRS complex duration (s) 0.11 ± 0.11 0.12 ± 0.14 0.045
Ventricular activation time in V1 (s) 0.03 ± 0.04 0.05 ± 0.04 0.002
Corrected QT interval (s) 0.44 ± 0.07 0.45 ± 0.03 0.045
R wave in the lead II (mV) 0.56 ± 0.26 0.34 ± 0.25 <0.001
R wave in aVF (mV) 0.31 ± 0.22 0.18 ± 0.14 0.005
S wave in V1 (SV1) (mV) 0.77 ± 0.55 0.52 ± 0.49 0.020
R wave in V5 (RV5) (mV) 1.16 ± 0.56 0.88 ± 0.52 0.031
R wave in V6 (RV6) (mV) 1.05 ± 0.54 0.74 ± 0.42 0.012
Maximal R wave in V5 or V6 (mV) 1.22 ± 0.56 0.92 ± 0.51 0.023
SV1 + RV5 or RV6 (mV) 1.99 ± 0.72 1.44 ± 0.75 <0.001
Romhilt–Estes 5. criterion (1 point if QRS duration >0.09 s) (points) 0.38 ± 0.49 0.68 ± 0.48 0.023
Romhilt–Estes 5. criterion positive results (n (%)) 20 (38.5) 23 (67.7) 0.008
Romhilt–Estes Score (points) 2.13 ± 2.09 3.00 ± 2.32 0.063
Romhilt–Estes Score positive results for probable LVH (LVH is likely with 4 or more points) (n (%)) 10 (19.2) 13 (38.2) 0.052
Romhilt–Estes Score positive results for LVH (LVH is present with 5 or more points) (n (%)) 4 (7.7) 7 (20.6) 0.079
Open in a new tab

Fig. 1.

Fig. 1

Open in a new tab

Kaplan–Meier survival probability of centenarians classified according to a amplitude of R wave in lead II ≥0.45 mV versus lower values, b amplitude of R wave in lead II ≥0.35 mV versus lower values, c Sokolow–Lyon voltage ≥1.45 mV versus lower values, and d QRS complex duration <90 ms versus higher values

Table 2.

Correlations between clinical or laboratory measures and ECG measures in centenarians (n = 86)

Clinical and laboratory measures ECG measures Spearman’s rank correlation coefficient P value
BMI (body mass index) R wave in II −0.213 0.049
R wave in V5 −0.245 0.023
R wave in V5 or V6 −0.233 0.031
S wave in V1 + R wave in V5 or V6 −0.242 0.024
WHR (waist to hip ratio) S wave in V1 + R wave in V5 or V6 −0.269 0.013
Systolic blood pressure R wave in II 0.261 0.015
R wave in aVF 0.307 0.004
R wave in V5 0.223 0.039
R wave in V5 or V6 0.262 0.015
S wave in V1 0.250 0.020
S wave in V1 + R wave in V5 or V6 0.261 0.015
Pulse pressure Heart rate −0.316 0.003
R wave in aVF 0.239 0.026
R wave in V6 0.304 0.004
S wave in V1 0.316 0.003
S wave in V1 + R wave in V5 or V6 0.335 0.002
CRPa QRS complex duration 0.216 0.049
Ventricular activation time in V1 0.302 0.005
Bilirubina QRS complex duration 0.256 0.019
Vitamin B12a S wave in V1 0.254 0.022
Leptinb R wave in V5 −0.331 0.030
Sodiumc R wave in II 0.327 0.025
Calciumc R wave in II 0.400 0.004
R wave in aVF 0.307 0.032
R wave in V5 0.316 0.027
R wave in V6 0.299 0.037
S wave in V1 + R wave in V5 or V6 0.312 0.029
Phosphorus (inorganic)c S wave in V1 0.447 0.001
S wave in V1 + R wave in V5 or V6 0.383 0.007
Cornell Voltage value (R wave in aVL + S wave in V3) 0.445 0.001
eGFR (CKD-EPI creatinine–cystatin C equation) Heart rate −0.273 0.012
QRS complex duration −0.237 0.030
eGFR (BIS_creatinine-cystatin C equation) R wave in aVF 0.235 0.031
Interleukin 6b R wave in V5 −0.328 0.028
R wave in V6 −0.317 0.034
R wave in V5 or V6 −0.333 0.025
S wave in V1 −0.343 0.021
S wave in V1 + R wave in V5 or V6 −0.526 0.000
Tumor necrosis factor alphab Corrected QT interval 0.307 0.040
Plasminogen activator inhibitor-1b S wave in V1 −0.347 0.023
Cornell Voltage value (R wave in aVL + S wave in V3) −0.489 0.001
Tissue inhibitor of metalloproteinases 1b Romhilt–Estes Score 0.313 0.041
Open in a new tab

aSerum level, assessed in 84 subjects

bSerum level, assessed in 43 subjects

cSerum level, assessed in 49 subjects

Discussion

We found normal ECGs in 8.4 % of 86 study participants, which is consistent with other studies in the literature. Normal ECGs were observed in 5.7 % of 35 (Klich-Raczka et al. 2003), 7.6 % of 132 (Lakkireddy et al. 2003), 8.8 % of 80 (Rabunal-Rey et al. 2012), 16.7 % of 42 (Basile et al. 2012), and 26.2 % of 103 centenarians (Martínez-Sellés et al. 2015) in different study participants.

Commonly observed ECG abnormalities in our study group included atrial fibrillation, conduction defects, ST-segment depression, and left axis deviation. Permanent atrial fibrillation in our patients (20.9 %) occurred more frequently than observed by Klich-Raczka et al. (2003) (8.6 %) and Basile et al. (2012) (11.9 %), but less often than observed by Martínez-Sellés et al. (2015) (26.2 %), Rabunal-Rey et al. (2012) (26.3 %), or Lakkireddy et al. (2003) (29.5 %). Rabunal-Rey et al. (2012) demonstrated that atrial fibrillation is an independent risk factor for mortality. By contrast, Basile et al. (2012) did not find significant differences in age of death in relation to electrocardiographic findings. Lakkireddy et al. (2003) and Martínez-Sellés et al. (2015) did not report any relationship between ECG findings and mortality in centenarians.

Electrocardiographic assessment was positive for left ventricular hypertrophy in 6.98 to 12.8 % of participants in our study (depending on which ECG LVH assessment method was applied). In studies performed by Lakkireddy et al. (2003) and Basile et al. (2012), ECG features of LVH were found in 3 to 31 % of study participants. Martínez-Sellés et al. (2015) used echocardiography to diagnose left ventricular hypertrophy in 45 % of 100 centenarians, while only 5.1 % had ECG features of LVH. False-negative ECG-LVH may be associated with hypertension, increased systolic blood pressure, and prolonged QRS (Bacharova et al. 2015). These factors commonly exist in centenarians (Moubarak et al. 2012; Andersen-Ranberg et al. 2013; Szewieczek et al. 2015a; Szewieczek et al. 2015b).

Regardless of accuracy, ECG-LVH is associated with increased risk of cardiovascular events (Kannel et al. 1970; Bacharova et al. 2015; Porthan et al. 2015). Estes et al. (2015) found that four out of the six ECG components of the Romhilt–Estes score, beyond left axis deviation and prolonged QRS duration, were predictive of all-cause mortality in the general population. In previous studies, we observed a positive relationship between elevated blood pressure and 180-day survival (Szewieczek et al. 2015a) and between hypertension and 360-day survival (Szewieczek et al. 2015b) in centenarians.

Based on the association between QRS voltage and blood pressure (Van Hoof 1991), we expected a possible positive association between electrocardiographic LVH voltage criteria and survival in our study group. However, hypertension is a risk factor for left ventricular hypertrophy that is associated with an increased risk of ischemic heart disease, atrial fibrillation, heart failure, and mortality (Kannel et al. 1969; Kannel et al. 1970; Katholi and Couri 2011; Velagaleti et al. 2014; Cuspidi et al. 2015). Indeed, QRS voltage correlated positively with systolic blood pressure and pulse pressure (Table 2), and participants who survived 360 days had higher QRS voltage (Fig. 1).

Interestingly, LVH defined by a Romhilt–Estes score ≥5 in our study group was associated with decreased centenarian survival. This apparent contradiction may at least partially be explained by the high QRS voltage of the Romhilt–Estes LVH criteria (R wave amplitude greater than 2.0 mV in limb leads or R wave amplitude greater than 3.0 mV in leads V5 or V6) (Buxton et al. 2006). However, within our study population, we observed decreased survival probability at QRS amplitudes that were significantly lower than those suggested by the Romhilt–Estes criteria. Similarly, we found that the QRS amplitude cutoff for increased survival probability was also significantly lower (Fig. 1). These findings suggest that a positive Romhilt–Estes test for LVH and a low QRS voltage may be associated with decreased 360-day survival in our study group.

Low electrocardiographic QRS voltage (LQRSV) is traditionally defined by zenith-to-nadir QRS amplitudes of less than 0.5 mV in all limb leads and/or less than 1.0 mV in all the precordial leads (low limb, precordial, or total QRS voltages) (Madias 2008; Mussinelli et al. 2013). Etiologic factors include multiple cardiac, pericardial, and/or extra-cardiac causes (Madias 2008). LQRSV has been identified as a risk factor for increased mortality in individuals without apparent cardiovascular disease (Usoro et al. 2014) and in patients with acute coronary syndromes (Tan et al. 2015). Sokolow–Lyon voltage ≤1.5 mV is an alternative index of low QRS voltage (Austin et al. 2009). We were unable to prove an association between 360-day mortality and low QRS voltage in limb or precordial leads. Instead, we found such an association with low amplitude R waves in leads II and aVF, as well as a low Sokolow–Lyon voltage. The pathophysiology of the association between mortality and low amplitude of specific R waves in leads II and aVF is unclear.

Associations between mortality and decreased QRS voltage seem to be complex and may include common pathologies such as cardiomyocyte changes, diffuse myocardial fibrosis (Bacharova et al. 2015), and also amyloidosis which may be substantially more common than is currently recognized (Patel and Hawkins 2015). Sokolow–Lyon voltage correlates positively with left ventricular mass, left ventricular ejection fraction, and negatively with myocardial fibrosis in patients with hypertrophic cardiomyopathy (Konno et al. 2015).

Low QRS voltages were seen in 27.3 % of the light-chain (AL) amyloidosis patients and 12.9 % of the wild-type transthyretin amyloidosis (ATTRwt) patients (Pinney et al. 2013). ATTRwt, also known as senile cardiac amyloidosis, is an underdiagnosed disease that accounts for a significant number of elderly patients with heart failure with preserved ejection fraction (González-López et al. 2015). Low Sokolow–Lyon voltage is associated with a more severe myocardial infiltration in cardiac AL amyloidosis (Mussinelli et al. 2013) which can occur at any age (Patel and Hawkins 2015).

Study participants who did not survive 360 days as compared to survivors had a wider QRS complex, with increased right ventricular activation time. QRS widening is associated with increased risk for heart failure and mortality (Khan et al. 2007). The QRS interval can be affected by numerous factors, among them metabolic and inflammatory markers (Vanninen et al. 1996; Bacharova et al. 2012; Cetin et al. 2012). Focal or diffuse myocardial fibrosis, edema, inflammation, myocarditis, fatty replacement, or myocardial deposition of amyloid proteins may be determinants of myocardial tissue (Bacharova and Ugander 2014).

Inflammatory markers are elevated in patients with congestive heart failure and reflect disease severity (Lommi et al. 1997; Feldman et al. 2000). These observations may be substantiated by multiple associations between QRS voltage and various hemodynamic, metabolic, and inflammatory factors (systolic blood pressure, pulse pressure, serum vitamin B12, sodium, calcium, phosporus, TIMP-1 levels, and eGFR) found in our study, although elucidation of the significance of these relationships would benefit from further study.

Nonsurvivors as compared to survivors also had a longer QTc that correlated positively with TNF-α. QTc contributes independently to cardiovascular risk (Schouten et al. 1991). Kim et al. (2006) observed a relationship between CRP and QTc in middle-aged men and women. A similar relationship was observed in young, healthy men (Kazumi et al. 2003). Vasan et al. (2003) revealed an association between increased TNF-alpha, IL-6, and CRP levels in elderly patients and increased risk of congestive heart failure. Inflammation associated with rheumatoid arthritis was found to affect QTc (Panoulas et al. 2014).

Multiple metabolic and inflammatory factors may affect centenarian survival, influence heart structure and function, and therefore reflect characteristic ECG findings. These findings are generally consistent with other observations in the literature. As such, the importance of ECG characteristics as predictors of centenarian survival may signify more than simply a reflection of the cardiovascular health of the patient.

Criticism of the presented study encompasses low inclusion rate of candidates, which resulted in an extension of the observation period. Additionally, this study was based on a relatively small patient population. We were unable to complement our study with echocardiography that would substantially extend basis for data interpretation. These difficulties resulted mainly from the nature of the Polish centenarian cohort.

We demonstrated that a low QRS voltage and a wide QRS complex may be predictive of 360-day mortality among study participants. According to an extensive literature search, this is the first such published observation in centenarians. Since ECG remains one of the most accessible and noninvasive methods of health assessment, these findings may be useful for making diagnostic and therapeutic decisions in the oldest old patients.

Conclusions

Results suggest that Romhilt–Estes LVH criteria scores ≥5 points, low ECG QRS voltages (Sokolow–Lyon voltage <1.45 mV), and QRS complexes ≥90 ms are predictive of centenarian 360-day mortality.

Acknowledgments

The study was funded by the Medical University of Silesia, Katowice, Poland (grants nos. NN-2-268/06, KNW-2-045/08, KNW-2-022/09), and by the National Science Centre, Poland (grant no. 404 535439), from the budget for science in years 2010–2014.

References

  1. Andersen-Ranberg K, Fjederholt KT, Madzak A, Nybo M, Jeune B. Cardiovascular diseases are largely underreported in Danish centenarians. Age Ageing. 2013;42:249–253. doi: 10.1093/ageing/afs108. [DOI] [PubMed] [Google Scholar]
  2. Austin BA, Duffy B, Tan C, Rodriguez ER, Starling RC, Desai MY. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol. 2009;103:1429–1433. doi: 10.1016/j.amjcard.2009.01.361. [DOI] [PubMed] [Google Scholar]
  3. Bacharova L, Krivosikova Z, Wsolova L, Gajdos M. Alterations in the QRS complex in the offspring of patients with metabolic syndrome and diabetes mellitus: early evidence of cardiovascular pathology. J Electrocardiol. 2012;45:244–251. doi: 10.1016/j.jelectrocard.2012.02.004. [DOI] [PubMed] [Google Scholar]
  4. Bacharova L, Ugander M. Left ventricular hypertrophy: the relationship between the electrocardiogram and cardiovascular magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2014;19:524–533. doi: 10.1111/anec.12223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bacharova L, Chen H, Estes EH, Mateasik A, Bluemke DA, Lima JA, Burke GL, Soliman EZ. Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging. Am J Cardiol. 2015;115:515–522. doi: 10.1016/j.amjcard.2014.11.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Basile G, Cucinotta MD, Figliomeni P, Lo Balbo C, Maltese G, Lasco A. Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature. Gerontology. 2012;58:216–220. doi: 10.1159/000330801. [DOI] [PubMed] [Google Scholar]
  7. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology) Circulation. 2006;114:2534–2570. doi: 10.1161/CIRCULATIONAHA.106.180199. [DOI] [PubMed] [Google Scholar]
  8. Cetin M, Kocaman SA, Canga A, Durakoglugil ME, Erdogan T, Satiroglu O, Kiris T, Ugurlu Y, Cicek Y, Bostan M. The independent relationship between systemic inflammation and fragmented QRS complexes in patients with stable angina pectoris. Kardiol Pol. 2012;70:668–675. [PubMed] [Google Scholar]
  9. Cuspidi C, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, Mancia G. Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: the Pamela study. J Hypertens. 2015;33:2133–2140. doi: 10.1097/HJH.0000000000000658. [DOI] [PubMed] [Google Scholar]
  10. Estes EH, Zhang ZM, Li Y, Tereschenko LG, Soliman EZ. The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population. Am Heart J. 2015;170:104–109. doi: 10.1016/j.ahj.2015.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537–544. doi: 10.1016/S0735-1097(99)00600-2. [DOI] [PubMed] [Google Scholar]
  12. González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36:2585–2594. doi: 10.1093/eurheartj/ehv338. [DOI] [PubMed] [Google Scholar]
  13. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 1969;71:89–105. doi: 10.7326/0003-4819-71-1-89. [DOI] [PubMed] [Google Scholar]
  14. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med. 1970;72:813–822. doi: 10.7326/0003-4819-72-6-813. [DOI] [PubMed] [Google Scholar]
  15. Katholi RE, Couri DM (2011) Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens 2011:495349 [DOI] [PMC free article] [PubMed]
  16. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism. 2003;52:1113–1116. doi: 10.1016/S0026-0495(03)00184-7. [DOI] [PubMed] [Google Scholar]
  17. Khan NK, Goode KM, Cleland JG, Rigby AS, Freemantle N, Eastaugh J, Clark AL, de Silva R, Calvert MJ, Swedberg K, Komajda M, Mareev V, Follath F, EuroHeart Failure Survey Investigators Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail. 2007;9:491–501. doi: 10.1016/j.ejheart.2006.11.003. [DOI] [PubMed] [Google Scholar]
  18. Kim E, Joo S, Kim J, Ahn J, Kim J, Kimm K, Shin C. Association between C-reactive protein and QTc interval in middle-aged men and women. Eur J Epidemiol. 2006;21:653–659. doi: 10.1007/s10654-006-9034-9. [DOI] [PubMed] [Google Scholar]
  19. Klich-Raczka A, Zyczkowska J, Grodzicki T. Electrocardiogram in centenarians. Kardiol Pol. 2003;58:275–281. [PubMed] [Google Scholar]
  20. Konno T, Nagata Y, Teramoto R, Fujino N, Nomura A, Tada H, Sakata K, Furusho H, Takamura M, Nakamura H, Kawashiri MA, Yamagishi M, Hayashi K (2015) Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy. Am J Cardiol. doi:10.1016/j.amjcard.2015.11.015 [Epub ahead of print] [DOI] [PubMed]
  21. Lakkireddy DR, Clark RA, Mohiuddin SM. Electrocardiographic findings in patients >100 years of age without clinical evidence of cardiac disease. Am J Cardiol. 2003;92:1249–1251. doi: 10.1016/j.amjcard.2003.07.046. [DOI] [PubMed] [Google Scholar]
  22. Lommi J, Pulkki K, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J. 1997;18:1620–1625. doi: 10.1093/oxfordjournals.eurheartj.a015142. [DOI] [PubMed] [Google Scholar]
  23. Madias JE. Low QRS voltage and its causes. J Electrocardiol. 2008;41:498–500. doi: 10.1016/j.jelectrocard.2008.06.021. [DOI] [PubMed] [Google Scholar]
  24. Martínez-Sellés M, García de la Villa B, Cruz-Jentoft AJ, Vidán MT, Gil P, Cornide L, Ramos Cortés M, González Guerrero JL, Barros Cerviño SM, Díaz Castro Ó, et al. Centenarians and their hearts: a prospective registry with comprehensive geriatric assessment, electrocardiogram, echocardiography, and follow-up. Am Heart J. 2015;169:798–805. doi: 10.1016/j.ahj.2015.03.005. [DOI] [PubMed] [Google Scholar]
  25. Moubarak G, Algalarrondo V, Badenco N, Guiot A, Guillausseau PJ, Bergmann JF, Bardin T, Leenhardt A, Solal AC. Electrocardiographic abnormalities in centenarians and octogenarians: a case-matched study. Ann Noninvasive Electrocardiol. 2012;17:372–377. doi: 10.1111/j.1542-474X.2012.00532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mussinelli R, Salinaro F, Alogna A, Boldrini M, Raimondi A, Musca F, Palladini G, Merlini G, Perlini S. Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis. Ann Noninvasive Electrocardiol. 2013;18:271–280. doi: 10.1111/anec.12036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Patel KS, Hawkins PN. Cardiac amyloidosis: where are we today? J Intern Med. 2015;278:126–144. doi: 10.1111/joim.12383. [DOI] [PubMed] [Google Scholar]
  28. Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 2014;53:131–137. doi: 10.1093/rheumatology/ket338. [DOI] [PubMed] [Google Scholar]
  29. Pinney JH, Whelan CJ, Petrie A, Dungu J, Banypersad SM, Sattianayagam P, Wechalekar A, Gibbs SD, Venner CP, Wassef N, McCarthy CA, Gilbertson JA, Rowczenio D, Hawkins PN, Gillmore JD, Lachmann HJ. Senile systemic amyloidosis: clinical features at presentation and outcome. J Am Heart Assoc. 2013;2:e000098. doi: 10.1161/JAHA.113.000098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Porthan K, Niiranen TJ, Varis J, Kantola I, Karanko H, Kähönen M, Nieminen MS, Salomaa V, Huikuri HV, Jula AM. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population. J Hypertens. 2015;33:1284–1290. doi: 10.1097/HJH.0000000000000553. [DOI] [PubMed] [Google Scholar]
  31. Rabunal-Rey R, Monte-Secades R, Gomez-Gigirey A, Pertega-Diaz S, Testa-Fernandez A, Pita-Fernandez S, Casariego-Vales E. Electrocardiographic abnormalities in centenarians: impact on survival. BMC Geriatr. 2012;12:15. doi: 10.1186/1471-2318-12-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84:1516–1523. doi: 10.1161/01.CIR.84.4.1516. [DOI] [PubMed] [Google Scholar]
  33. Szewieczek J, Dulawa J, Gminski J, Kurek A, Legierska K, Francuz T, Włodarczyk-Sporek I, Janusz-Jenczen M, Hornik B. Better cognitive and physical performance is associated with higher blood pressure in centenarians. J Nutr Health Aging. 2011;15:618–622. doi: 10.1007/s12603-011-0334-8. [DOI] [PubMed] [Google Scholar]
  34. Szewieczek J, Duława J, Francuz T, Legierska K, Hornik B, Włodarczyk-Sporek I, Janusz-Jenczeń M, Batko-Szwaczka A. Mildly elevated blood pressure is a marker for better health status in Polish centenarians. Age (Dordr) 2015;37:9738. doi: 10.1007/s11357-014-9738-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Szewieczek J, Francuz T, Dulawa J, Legierska K, Hornik B, Włodarczyk I, Janusz-Jenczeń M, Batko-Szwaczka A (2015b) Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians. Age. doi:10.1007/s11357-015-9822-9 [DOI] [PMC free article] [PubMed]
  36. Tan NS, Goodman SG, Yan RT, Tan MK, Fox KA, Gore JM, Brieger D, Steg PG, Langer A, Yan AT, GRACE ECG substudy and Canadian ACS I Registry investigators Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes. Int J Cardiol. 2015;190:34–39. doi: 10.1016/j.ijcard.2015.04.085. [DOI] [PubMed] [Google Scholar]
  37. Usoro AO, Bradford N, Shah AJ, Soliman EZ. Risk of mortality in individuals with low QRS voltage and free of cardiovascular disease. Am J Cardiol. 2014;113:1514–1517. doi: 10.1016/j.amjcard.2014.02.006. [DOI] [PubMed] [Google Scholar]
  38. Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D’Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol. 2014;113:117–122. doi: 10.1016/j.amjcard.2013.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Van Hoof R. Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial. Am J Med. 1991;90:55S–59S. doi: 10.1016/0002-9343(91)90438-4. [DOI] [PubMed] [Google Scholar]
  40. Vanninen E, Unsitupa MI, Länsimies E. Ventricular repolarization is correlated with metabolic control in newly diagnosed type 2 diabetes. Clin Physiol. 1996;16:449–461. doi: 10.1111/j.1475-097X.1996.tb00732.x. [DOI] [PubMed] [Google Scholar]
  41. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D’Agostino RB. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003;107:1486–1491. doi: 10.1161/01.CIR.0000057810.48709.F6. [DOI] [PubMed] [Google Scholar]

Articles from Age are provided here courtesy of American Aging Association

RESOURCES